Works by Kyu-Chang Won

Results: 62
    1
    2
    3
    4
    5
    6

    A Short but Long Journey with You.

    Published in:
    Diabetes & Metabolism Journal, 2018, v. 42, n. 1, p. 1, doi. 10.4093/dmj.2018.42.1.1
    By:
    • Kyu Chang Won
    Publication type:
    Article
    7
    8
    9
    10
    11
    12
    13
    14
    15
    16
    17
    18
    19
    20
    21
    22
    23
    24
    25
    26

    1140-P: Efficacy and Safety of Evogliptin in Patients with Type 2 Diabetes: A Multicenter, Active-Controlled, Randomized Study with Open Label Extension (EVERGREEN Study).

    Published in:
    Diabetes, 2019, v. 68, p. N.PAG, doi. 10.2337/db19-1140-P
    By:
    • LIM, SOO;
    • KIM, GYURI;
    • KWON, HYUK-SANG;
    • PARK, IE BYUNG;
    • AHN, KYU JEUNG;
    • PARK, CHEOL-YOUNG;
    • KWON, SU KYOUNG;
    • KIM, HYE SOON;
    • PARK, SEOK WON;
    • KIM, SIN GON;
    • MOON, MIN KYONG;
    • KIM, EUNSOOK;
    • CHUNG, CHOON H.;
    • WON, KYU CHANG;
    • PARK, KANG SEO;
    • KIM, MIKYUNG;
    • CHUNG, DONG JIN;
    • LEE, CHANG BEOM;
    • KIM, TAE HO;
    • LEE, MOON-KYU
    Publication type:
    Article
    27

    Basal-prandial versus premixed insulin in patients with type 2 diabetes requiring insulin intensification after basal insulin optimization: A 24-week randomized non-inferiority trial 接受基础胰岛素优化治疗之后需要胰岛素强化治疗的患者使用基础-餐时胰岛素治疗与使用预混胰岛素治疗的对照试验:一项为期24周的随机非劣性试验

    Published in:
    Journal of Diabetes, 2016, v. 8, n. 3, p. 405, doi. 10.1111/1753-0407.12312
    By:
    • Jin, Sang ‐ Man;
    • Kim, Jae Hyeon;
    • Min, Kyung Wan;
    • Lee, Ji Hyun;
    • Ahn, Kue Jeong;
    • Park, Jeong Hyun;
    • Jang, Hak Chul;
    • Park, Seok Won;
    • Lee, Kwan Woo;
    • Won, Kyu Chang;
    • Kim, Young ‐ Il;
    • Chung, Choon Hee;
    • Park, Tae Sun;
    • Lee, Jee ‐ Hyun;
    • Lee, Moon ‐ Kyu
    Publication type:
    Article
    28
    29
    30
    31

    The Efficacy and Safety of Moderate-Intensity Rosuvastatin with Ezetimibe versus High-Intensity Rosuvastatin in High Atherosclerotic Cardiovascular Disease Risk Patients with Type 2 Diabetes Mellitus: A Randomized, Multicenter, Open, Parallel, Phase 4 Study

    Published in:
    Diabetes & Metabolism Journal, 2023, v. 47, n. 6, p. 818, doi. 10.4093/dmj.2023.0171
    By:
    • Jun Sung Moon;
    • Il Rae Park;
    • Sang Soo Kim;
    • Hye Soon Kim;
    • Nam Hoon Kim;
    • Sin Gon Kim;
    • Seung Hyun Ko;
    • Ji Hyun Lee;
    • Inkyu Lee;
    • Bo Kyeong Lee;
    • Kyu Chang Won
    Publication type:
    Article
    32

    Efficacy and Safety of Evogliptin Add-on Therapy to Dapagliflozin/Metformin Combinations in Patients with Poorly Controlled Type 2 Diabetes Mellitus: A 24-Week Multicenter Randomized Placebo-Controlled Parallel-Design Phase-3 Trial with a 28-Week Extension

    Published in:
    Diabetes & Metabolism Journal, 2023, v. 47, n. 6, p. 808, doi. 10.4093/dmj.2022.0387
    By:
    • Jun Sung Moon;
    • Il Rae Park;
    • Hae Jin Kim;
    • Choon Hee Chung;
    • Kyu Chang Won;
    • Kyung Ah Han;
    • Cheol-Young Park;
    • Jong Chul Won;
    • Dong Jun Kim;
    • Gwan Pyo Koh;
    • Eun Sook Kim;
    • Jae Myung Yu;
    • Eun-Gyoung Hong;
    • Chang Beom Lee;
    • Kun-Ho Yoon
    Publication type:
    Article
    33
    34
    35

    Diabetes Fact Sheet in Korea 2021.

    Published in:
    Diabetes & Metabolism Journal, 2022, v. 46, n. 3, p. 417, doi. 10.4093/dmj.2022.0106
    By:
    • Jae Hyun Bae;
    • Kyung-Do Han;
    • Seung-Hyun Ko;
    • Ye Seul Yang;
    • Jong Han Choi;
    • Kyung Mook Choi;
    • Hyuk-Sang Kwon;
    • Kyu Chang Won
    Publication type:
    Article
    36
    37
    38
    39
    40
    41
    42
    43
    44
    45
    46
    47
    48
    49

    Efficacy and safety of monotherapy with enavogliflozin in Korean patients with type 2 diabetes mellitus: Results of a 12‐week, multicentre, randomized, double‐blind, placebo‐controlled, phase 2 trial.

    Published in:
    Diabetes, Obesity & Metabolism, 2023, v. 25, n. 8, p. 2096, doi. 10.1111/dom.15080
    By:
    • Yang, Ye Seul;
    • Min, Kyung Wan;
    • Park, Seok‐O;
    • Kim, Kyung‐Soo;
    • Yu, Jae Myung;
    • Hong, Eun‐Gyoung;
    • Cho, Sung Rae;
    • Won, Kyu Chang;
    • Kim, Yong Hyun;
    • Oh, Seungjoon;
    • Choi, Sung Hee;
    • Koh, Gwanpyo;
    • Huh, Wan;
    • Kim, Su Young;
    • Park, Kyong Soo
    Publication type:
    Article
    50

    Efficacy and safety of enavogliflozin, a novel SGLT2 inhibitor, in Korean people with type 2 diabetes: A 24‐week, multicentre, randomized, double‐blind, placebo‐controlled, phase III trial.

    Published in:
    Diabetes, Obesity & Metabolism, 2023, v. 25, n. 7, p. 1865, doi. 10.1111/dom.15046
    By:
    • Kwak, Soo Heon;
    • Han, Kyung Ah;
    • Kim, Kyung‐Soo;
    • Yu, Jae Myung;
    • Kim, EunSook;
    • Won, Jong Chul;
    • Kang, Jun Goo;
    • Chung, Choon Hee;
    • Oh, Seungjoon;
    • Choi, Sung Hee;
    • Won, Kyu Chang;
    • Kim, Sin Gon;
    • Cho, Seung Ah;
    • Cho, Bo Young;
    • Park, Kyong Soo
    Publication type:
    Article